KELLY PADGETT: Open Payments
NPI 1689133456 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 71 payments from 21 companies in 2025. Trend: 2023 $536 · 2024 $1,265 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $268 |
| Novo Nordisk Inc | 11 | $225 |
| AstraZeneca Pharmaceuticals LP | 7 | $188 |
| Lilly USA, LLC | 9 | $154 |
| Axsome Therapeutics, Inc. | 4 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $93 |
| SANOFI-AVENTIS U.S. LLC | 3 | $60 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| ViiV Healthcare Company | 2 | $50 |
| Verity Pharmaceuticals Inc. | 1 | $29 |
Products named: Ozempic, AIRSUPRA, VRAYLAR, JARDIANCE, Auvelity, Kerendia, MOUNJARO, QULIPTA.
Industry payments across TX — which companies pay providers there.
